Flixotide Inhaler 250 Mcg
Brand : glaxo smith kline pakistan
How it works
The exact mechanism of action of fluticasone is not known; however, it stimulates glucocorticoid receptors in humans that produces a potent anti-inflammatory response.
FLIXOTIDE INHALER 250 MCG 1'S
Requires Prescription (YES/NO)
It reduces symptoms and exacerbations of asthma in patients previously treated with bronchodilator alone or with other prophylactic therapy.
Very common : Candidiasis of mouth and throat Candidiasis of the mouth and throat (thrush) occurs in some patients. Such patients may find it helpful to rinse out their mouth with water after using the inhaler. Symptomatic candidiasis can be treated with topical anti-fungal therapy whilst still continuing with this medicine. Rare: Oesophageal candidiasis Immune system disorders Hypersensitivity reactions with the following manifestations have been reported: Uncommon: Cutaneous hypersensitivity reactions Very rare: Angioedema (mainly facial and oropharyngeal oedema), respiratory symptoms (dyspnoea and/or bronchospasm) and anaphylactic reactions Endocrine disorders Possible systemic effects include : Very rare: Cushing’s syndrome, Cushingoid features, adrenal suppression, growth retardation, decreased bone mineral density, cataract and glaucoma Metabolism and nutrition disorders Very rare: Hyperglycaemia Psychiatric disorders Very rare: Anxiety, sleep disorders and behavioural changes, including hyperactivity and irritability (predominantly in children) Respiratory, thoracic and mediastinal disorders : Common: Hoarseness In some patients inhaled fluticasone propionate may cause hoarseness. It may be helpful to rinse out the mouth with water immediately after inhalation Very rare: Paradoxical bronchospasm . Skin and subcutaneous tissue disorders Common: Contusions .
When not to Use
Do not use: if you are allergic to fluticasone propionate or the other ingredients of this medicine.
Adults : 100-1000mcg twice daily. Children : Under 4yr, not recommended. Over 4 yr, 50-100mcg twice daily. Max 200 mcg twice daily. Or As directed by your physician .
Storage yes or /no
Store this medicine at room temperature, away from direct light and heat.
Increasing use of short-acting inhaled ß2-agonists to control asthma symptoms indicates deterioration of asthma control. Under these conditions, the patient's therapy plan should be reassessed. Sudden and progressive deterioration in asthma control is potentially life-threatening and consideration should be given to increasing corticosteroid dosage. In patients considered at risk, daily peak flow monitoring may be instituted.
Patients inhaler technique should be checked to make sure that inhaler actuation is synchronised with inspiration to ensure optimum delivery of the medicine to the lungs.
It is recommended that the height of children receiving prolonged treatment with inhaled corticosteroid is regularly monitored.
Because of the possibility of impaired adrenal response, patients transferring from oral steroid therapy to inhaled fluticasone propionate therapy should be treated with special care, and adrenocortical function regularly monitored.
Always consult your physician before using any medicine.
Ritonavir , erythromycin , ketoconazole .
syr bd 1cc insulin 6mm syringe 1s
disprin 300mg dispersible tablets 100s (pack size 10 x 10s)
panadol 500mg tablets 200s ( pack size 20x10s)